Panelist: Innovations in Psychedelics, Funding and the Future

Top universities are opening psychedelic research centers and investors are funding innovation in the private sector. The pace of change is rapid. What does the emerging landscape look like and what should we be most excited and cautious about regarding the evolution of psychedelic medicines and therapies? Hear perspectives from leaders in the space about the evolving science and business of psychedelics.

More About Jerrold

Jerrold Rosenbaum, MD is psychiatrist-in-chief emeritus and director of the Center for Anxiety and Traumatic Stress Disorders, director of the Center for Neuroscience of Psychedelics at the Massachusetts General Hospital and Stanley Cobb Professor of Psychiatry at Harvard Medical School. His career has focused on mood and anxiety disorders, with a special emphasis on pharmacotherapy of those conditions. He is a co-founder of Psy Therapeutics.